Comparing treatments for myopia in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of pharmacological treatment with 0.05% atropine and non-pharmacological treatment using DIMS lenses on children with varying predicted rates of myopia progression. Over a 24-month period, 80 participants aged 7 to 9 years will undergo baseline and follow-up eye examinations to assess changes in refractive errors and axial length. The study will also investigate the relationship between retinal activity, measured by multifocal electroretinogram, and myopia progression. Participants will be classified into fast or slow myopia progression groups based on their initial retinal responses.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* be aged between 7 and 9 years
* have no reported eye disorder and no family history of eye disease
* be able to participate in this study for 24 months
* not have any current or history of epilepsy
* not have any current or history of asthma
* have refractive error between 0.50 D and 4.00 D and less than 1.50D of astigmatism with best corrected visual acuity of LogMAR 0.0 or better
* have no detected eye diseases or disorders after eye examination, except myopia

Where it's running

• School of Optometry, Hong Kong Polytechnic University
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Henry HL CHAN, PhD — The Hong Kong Polytechnic University
• Study coordinator: Henry HL CHAN, PhD
• Email: henryhl.chan@polyu.edu.hk
• Phone: 85227667937

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a device for screening vision problems in young children

  This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.

  Recruiting Essilor International · Nancy, France and 1 other locations · NCT06882408

• Optimizing light exposure to prevent and control myopia in children

  This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.

  Recruiting at 5 sites National University of Singapore · Singapore and 4 other locations · NCT06631339

• Hyperopic reserve screening for kindergartners in Beijing

  A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.

  Recruiting Beijing Tongren Hospital · Beijing · NCT07851532

• Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses

  This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.

  Recruiting Ohio State University · Columbus, Ohio · NCT07840209

• Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia

  This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.

  Recruiting CooperVision International Limited (CVIL) · New York, New York and 2 other locations · NCT07829419

• Seeing clearly in low light after Ray-Tracing guided LASIK

  A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.

  Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.